Aster DM Healthcare-Quality Care India merger advances with NCLT approval for shareholder meeting

INDIA—India’s healthcare sector is witnessing one of its most significant consolidations as the merger between Aster DM Healthcare Limited and Quality Care India Ltd moves closer to completion.

The Hon’ble National Company Law Tribunal (NCLT), Hyderabad Bench, has issued an order allowing the companies to convene meetings with shareholders and unsecured trade creditors to seek approval for the merger.

The crucial meetings will take place between February 27, 2026, and March 13, 2026, marking a pivotal moment in this landmark transaction.

The merger has already cleared several regulatory hurdles, having secured approval from the Competition Commission of India (CCI) and received ‘No Objection’ letters from the Stock Exchanges.

With these clearances in hand, the company anticipates completing the entire merger process by the first quarter of the fiscal year 2026-27, pending receipt of all remaining regulatory approvals and fulfillment of other prerequisite conditions.

A new healthcare powerhouse emerges

Once finalized, the merged entity will operate under the name ‘Aster DM Quality Care’ and will be jointly promoted by Aster Promoters and Blackstone.

This combination unites two leading healthcare providers who share a common vision of expanding access to high-quality medical care throughout India.

The collaboration aims to create a more robust healthcare infrastructure capable of serving millions of patients across the country.

Dr. Azad Moopen, Founder and Chairman of Aster DM Healthcare, expressed satisfaction with the substantial progress achieved in advancing the merger process.

He stated that the company remains confident in securing approval from shareholders and unsecured creditors following the NCLT order.

Dr. Moopen emphasized the organization’s commitment to expediting the completion of the merger and working diligently to make it effective by the first quarter of FY2026-27.

Strategic growth plans

Looking toward the future, the leadership team plans to execute a disciplined integration strategy that capitalizes on the complementary networks, clinical expertise, and operational strengths of both Aster and Quality Care.

Dr. Moopen explained that this merger creates a strong platform for scaling operations efficiently while enhancing clinical excellence and accelerating innovation.

The ultimate goal is to build a more resilient and future-ready healthcare organization that delivers improved access and better outcomes for patients throughout India.

 Expanded Capacity

The merged entity ‘Aster DM Quality Care Limited’ will manage a combined portfolio of four prominent healthcare brands: Aster DM, CARE Hospitals, KIMSHEALTH, and Evercare.

As of September 30, 2025, the combined organizations operate more than 10,360 beds, with Aster contributing over 5,195 beds and Quality Care India Ltd contributing over 5,165 beds, respectively.

The ambitious expansion plans include increasing the total bed capacity to approximately 14,715 beds over the coming years.

This substantial growth will enable the organization to serve more patients and expand its reach across different regions of India.

With this enhanced scale, the merged entity will be well-positioned to explore investments in advanced medical technologies and digital health platforms, driving innovation and creating a more integrated and seamless patient experience across all facilities.